Cerevel Therapeutics Inc... (CERE)
NASDAQ: CERE
· Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 8:00 PM
Cerevel Therapeutics Revenue
Cerevel Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2024, Cerevel Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
355
Market Cap
8.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|